Medical Services Sales Continue to Meet Expectations

November 8, 2005
Medical Services International Inc. (OTC: MSITF) sales continue to meet expectations. Medical Services International is pleased to announce that based on orders received to date from distributors that the projections of 400,000 VScan test kits for the second quarter will be exceeded. Based on information supplied by distributors, the Company now anticipates orders in excess of 500,000 VScan test kits in the second quarter.

The addition of a follow up TB test combined with the existing VScan TB test kit has created significant interest in the market. The Company is moving as quickly as possible to make the follow up test available for regulatory testing in our major markets.

About VScan ™

The VScan™ rapid test kit is a single use, easy to use, test for the screening of HIV 1&2, Hepatitis B&C, Tuberculosis (TB), Dengue Fever and West Nile, Malaria, Syphilis, and Prostate Cancer. The kits cannot be sold in Canada.

For further information contact:
Robert Talbot at 780-430-6363 or
Bill Whitehead, Jr., 416-822-5883

Medical Services International Inc. trades in the United States on the NQB Pinksheets under the symbol "MSITF".